Cepmra Inc


Analyst Feels Good About Cempra Inc (CEMP) Ahead Of solithromycin Release

Analyst Brian Skorney from Baird reiterated his Outperform rating on Cempra Inc (NSADAQ:CEMP) with a price target of $33, marking a 78% increase from …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts